Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Santhi D. Konduri"'
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 5, Iss 3, Pp 218-228 (2018)
Purpose: Reasons for the well-described disparity in outcomes between African American (AA) and non-Hispanic white (NHW) women with invasive breast cancer are unclear, making it difficult to identify solutions. This study examined the effects of demo
Externí odkaz:
https://doaj.org/article/be63e61876034938b290ba06e1321f33
Autor:
Santhi D. Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, Sanjay Kansra
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 2, Iss 4, Pp 156-164 (2015)
Purpose: Malignant clear cell renal carcinoma (ccRCC) is an aggressive tumor highly resistant to chemotherapy and radiation. Current therapeutic approaches to management of ccRCC have not significantly improved patient survival, therefore novel thera
Externí odkaz:
https://doaj.org/article/d39d0b49be6649e99e713da4efbe4149
Autor:
Cheryl H. Baker, Srivenugopal S. Kalkunte, Kishor K. Bhakat, Beth Isley, Jimmie Colon, Robert M. Sutphin, George C. Bobustuc, Jonathan Ticku, Santhi D. Konduri
Supplementary Data from Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6694d9878ec631ddc3f820944cb7255f
https://doi.org/10.1158/1078-0432.22440283.v1
https://doi.org/10.1158/1078-0432.22440283.v1
Autor:
Cheryl H. Baker, Srivenugopal S. Kalkunte, Kishor K. Bhakat, Beth Isley, Jimmie Colon, Robert M. Sutphin, George C. Bobustuc, Jonathan Ticku, Santhi D. Konduri
Purpose: We sought to determine whether administration of a MGMT blocker, O6-benzyl guanine (O6BG), at an optimal biological dose alone or in combination with gemcitabine inhibits human pancreatic cancer cell growth.Experimental Design: Human pancrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45146e61a02cb7da3cee4c1a36eda07b
https://doi.org/10.1158/1078-0432.c.6517633.v1
https://doi.org/10.1158/1078-0432.c.6517633.v1
Supplementary Methods, Figure Legend from Estrogen Receptor α Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20b542bd651bdff221a709daa081944
https://doi.org/10.1158/0008-5472.22368467
https://doi.org/10.1158/0008-5472.22368467
Supplementary Figure 1 from Estrogen Receptor α Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0702a7e45863e1ef7d98011ca85f2321
https://doi.org/10.1158/0008-5472.22368470
https://doi.org/10.1158/0008-5472.22368470
Estrogen receptor α (ERα) and tumor suppressor protein p53 exert opposing effects on cellular proliferation. As a transcriptional regulator, p53 is capable of activating or repressing various target genes. We have previously reported that ERα bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b97421cee169e547747c61d413a9e83
https://doi.org/10.1158/0008-5472.c.6495974.v1
https://doi.org/10.1158/0008-5472.c.6495974.v1
Publikováno v:
Cancer Research. 81:PS7-84
Background The presence of carcinoma cells in either lymphatic vessels, blood vessels or both is defined as lymphovascular invasion (LVI). The presence of LVI is associated with an increased risk of axillary lymph node and distant metastases. LVI is
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 54, Iss, Pp 8-14 (2020)
Breast, Vol 54, Iss, Pp 8-14 (2020)
Background Due to its rarity, few studies have characterized the epidemiology of male breast cancer. The purpose of this study was to determine survival and risk factors for male breast cancer in a large U.S. population. Methods In this study, 19,795
Autor:
Christina Adams, Creighton J Creighton, Chetan C. Oturkar, Benny Abraham Kaipparettu, Jun Hyoung Park, Nadi Wickramasekera, Sanjay Bansal, Wendy M. Swetzig, Laxmi Silwal-Pandit, Alka Mukhopadhyay, Santhi D. Konduri, Utpal K. Mukhopadhyay, Anne Lise Børresen-Dale, Alexander Caradori, Austin Miller, Gokul M. Das, Rajesh Medisetty
Publikováno v:
Cancer Research. 80:P3-10
Whether estrogen receptor beta (ERβ/ESR2) is a pro- or anti-oncogenic protein in breast cancer has been controversial. ERβ levels are generally high in triple-negative breast cancer (TNBC). Reports including the Cancer Genome Atlas (TCGA) show that